Associate Professor of Bioengineering at Stanford University; investigating novel mechanisms of Alzheimer's Disease & human innate immune system dysregulation.
We've just published a study in Frontiers in Neuroscience showing, in vivo in mice, that daily, 30-min Red/Near-IR Light treatments are protective against both systemic and neuronal inflammation that otherwise occur in response to an LPS injection: https://t.co/1BRs1fMrDR
This is so important: anti-Epstein-Barr drugs are now being investigated as potential treatments for cancer and autoimmune disease.
We believe we’re heading in a similar direction for the SARS-CoV-2 virus, which evidence increasingly shows can persists within the human body— both in people with AND without Long COVID symptoms.
Progress has been slow, due to lack of vision on the part of government funders and big pharma.
We’re doing our best to change that, ASAP.
.@Nature has just published pivotal findings on GD2-CAR T-cell therapy for childhood brain cancer – a novel therapy that recently received Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA. https://t.co/WXGf4KDKWs (1/3)
We used a commercially available light therapy device to do the research, called the Auragen™ unit from a company called Reversal Solutions. You can obtain the unit here: https://t.co/bHYdZrBZom
We've just published a study in Frontiers in Neuroscience showing, in vivo in mice, that daily, 30-min Red/Near-IR Light treatments are protective against both systemic and neuronal inflammation that otherwise occur in response to an LPS injection: https://t.co/1BRs1fMrDR
A new review & hypothesis paper I published with distinguished co-authors in Frontiers in Immunology: "Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis" https://t.co/Q9OmKelJsj
We have published a new review in Lancet Infectious Diseases.
We aim to define a framework for the analysis of non-specific effects of live attenuated vaccines against vaccine-unrelated infections with pandemic potential. https://t.co/Pfv0LAtK9W
#MassGeneral physician @FaustmanLab Denise Faustman, MD, was quoted in @BostonGlobe's article on a study she led, which found that the BCG tuberculosis vaccine may also protect against #COVID19. https://t.co/lvB4EtAKWw
#MassGeneral physician @FaustmanLab Denise Faustman, MD, was quoted in @BostonGlobe's article on a study she led, which found that the BCG tuberculosis vaccine may also protect against #COVID19. https://t.co/lvB4EtAKWw
Our new publication with excellent co-authors, just published in ACS Infectious Diseases: "Anti-persister and Anti-biofilm Activity of Self-Assembled Antimicrobial Peptoid Ellipsoidal Micelles" https://t.co/cAPrGvr4xk
Grateful to philanthropist Dr. James J. Truchard & UT San Antonio @alzheimersprize for having won #TheOskarFischerPrize!!
Award symposium is in San Antonio on July 22; ten Oskar Fischer Prize winners will all meet and plan exciting new collaborations!
https://t.co/9PVoV12iHj
Alongside @annelise_b and scientists at @MaxwellBiosci we have co-invented drug candidates that NIAID at @NIH has confirmed in Syrian Hamsters - fully effective at preventing the symptoms of #Covid_19. #COVID#CovidIsNotOver#Omicron
Should I keep the public updated via Twitter?
@StabellBenn@ProfJLundgren@BeichAnders@unherd@StanfordMed Christine, thank God for you, Dr. Peter Aaby, Dr. Mihai Netea and your other collaborators, and for the important analytical work that you do!
Your voice is so important.